×
Volver a Agenda
Session Chair(s)
Pete Mallow, PHD
Assistant Director, Health Economics
CTI Clinical Trial and Consulting, United States
Learning Objective : Define factors affecting orphan drug pricing, reimbursement, and market access; Develop familiarity with economic simulation methods; Appraise different model input values that affect key outcomes of interest.
Speaker(s)
Rare Diseases: Background and Implications for the Pricing, Economics, Reimbursement, Market Share (PERMS) Strategy
William Irish
CTI Clinical Trial and Consulting Services, United States
Vice President, Health Outcomes Research and Biostatistics
Economic Aspects of Pricing, Health Economics, Reimbursement, Market Share (PERMS) Strategy
John Rizzo, PHD, MA
Stony Brook University, United States
Professor, Economics and Preventative Medicine, Program in Public Health
¿Tiene una cuenta?